Source: Endocrine. Unidade: FM
Subjects: NEOPLASIAS DA TIREOIDE, METÁSTASE NEOPLÁSICA, REAÇÃO EM CADEIA POR POLIMERASE, EXPRESSÃO GÊNICA, DNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GALRÃO, A. L. et al. Methylation levels of sodium–iodide symporter (NIS) promoter in benign and malignant thyroid tumors with reduced NIS expression. Endocrine, v. 43, n. 1, p. 225-229, 2013Tradução . . Disponível em: http://link.springer.com/content/pdf/10.1007%2Fs12020-012-9779-8.pdf. Acesso em: 01 nov. 2024.APA
Galrão, A. L., Sodré, A. K., Camargo, R. Y., Friguglietti, C. U., Kulcsar, M. A., Lima, E. U., et al. (2013). Methylation levels of sodium–iodide symporter (NIS) promoter in benign and malignant thyroid tumors with reduced NIS expression. Endocrine, 43( 1), 225-229. doi:10.1007/s12020-012-9779-8NLM
Galrão AL, Sodré AK, Camargo RY, Friguglietti CU, Kulcsar MA, Lima EU, Medeiros-Neto G, Rubio IGS. Methylation levels of sodium–iodide symporter (NIS) promoter in benign and malignant thyroid tumors with reduced NIS expression [Internet]. Endocrine. 2013 ; 43( 1): 225-229.[citado 2024 nov. 01 ] Available from: http://link.springer.com/content/pdf/10.1007%2Fs12020-012-9779-8.pdfVancouver
Galrão AL, Sodré AK, Camargo RY, Friguglietti CU, Kulcsar MA, Lima EU, Medeiros-Neto G, Rubio IGS. Methylation levels of sodium–iodide symporter (NIS) promoter in benign and malignant thyroid tumors with reduced NIS expression [Internet]. Endocrine. 2013 ; 43( 1): 225-229.[citado 2024 nov. 01 ] Available from: http://link.springer.com/content/pdf/10.1007%2Fs12020-012-9779-8.pdf
